Literature DB >> 11845001

Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines for chronic obstructive pulmonary disease.

Federico P Gómez1, Roberto Rodriguez-Roisin.   

Abstract

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) was developed recently to unify international efforts in the management of the disease. The most important GOLD objective is raising awareness that chronic obstructive pulmonary disease is an increasing health problem. The first step in the GOLD program was to prepare a consensus report, named "Global Strategy for the Diagnosis, Management, and Prevention of COPD," based on best-validated evidence and current pathogenetic and clinical knowledge. It encourages implementation of effective strategies for prevention, diagnosis, and management of the disease in all countries, and emphasizes the importance of renewed research initiatives.

Entities:  

Mesh:

Year:  2002        PMID: 11845001     DOI: 10.1097/00063198-200203000-00001

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  35 in total

1.  Treatment of chronic obstructive pulmonary disease: Combination or component therapy?

Authors:  Daniel G Hackam
Journal:  CMAJ       Date:  2003-05-13       Impact factor: 8.262

2.  MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD.

Authors:  Alan C-Y Hsu; Kamal Dua; Malcolm R Starkey; Tatt-Jhong Haw; Prema M Nair; Kristy Nichol; Nathan Zammit; Shane T Grey; Katherine J Baines; Paul S Foster; Philip M Hansbro; Peter A Wark
Journal:  JCI Insight       Date:  2017-04-06

3.  Right ventricular outflow tract function in chronic obstructive pulmonary disease.

Authors:  B Geyik; N Tarakci; O Ozeke; C Ertan; M Gul; S Topaloglu; D Aras; A D Demir; O Tufekcioglu; Z Golbasi; S Aydogdu
Journal:  Herz       Date:  2013-11-01       Impact factor: 1.443

4.  COPD and levels of Hsp70 (HSPA1A) and Hsp27 (HSPB1) in plasma and lymphocytes among coal workers: a case-control study.

Authors:  Xiuqing Cui; Jingcai Xing; Yuewei Liu; Yun Zhou; Xin Luo; Zhihong Zhang; Wenhui Han; Tangchun Wu; Weihong Chen
Journal:  Cell Stress Chaperones       Date:  2015-01-27       Impact factor: 3.667

5.  HIV and COPD: impact of risk behaviors and diseases on quality of life.

Authors:  M Bradley Drummond; Gregory D Kirk; Meredith C McCormack; Mariah M Marshall; Erin P Ricketts; Shruti H Mehta; Robert A Wise; Christian A Merlo
Journal:  Qual Life Res       Date:  2010-07-09       Impact factor: 4.147

6.  Effect of emphysema on lung cancer risk in smokers: a computed tomography-based assessment.

Authors:  Yan Li; Stephen J Swensen; Leman Günbey Karabekmez; Randolph S Marks; Shawn M Stoddard; Ruoxiang Jiang; Joel B Worra; Fang Zhang; David E Midthun; Mariza de Andrade; Yong Song; Ping Yang
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-30

7.  Effect of smoking on lung function, respiratory symptoms and respiratory diseases amongst HIV-positive subjects: a cross-sectional study.

Authors:  Qu Cui; Sue Carruthers; Andrew McIvor; Fiona Smaill; Lehana Thabane; Marek Smieja
Journal:  AIDS Res Ther       Date:  2010-03-19       Impact factor: 2.250

8.  Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV.

Authors:  M Bradley Drummond; Gregory D Kirk; Erin P Ricketts; Meredith C McCormack; J Christian Hague; John F McDyer; Shruti H Mehta; Eric A Engels; Robert A Wise; Christian A Merlo
Journal:  BMC Pulm Med       Date:  2010-05-11       Impact factor: 3.317

Review 9.  Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease.

Authors:  Joanna L Richens; Richard A Urbanowicz; Elizabeth A M Lunt; Rebecca Metcalf; Jonathan Corne; Lucy Fairclough; Paul O'Shea
Journal:  Respir Res       Date:  2009-04-22

Review 10.  Obstructive Lung Diseases in HIV: A Clinical Review and Identification of Key Future Research Needs.

Authors:  M Bradley Drummond; Ken M Kunisaki; Laurence Huang
Journal:  Semin Respir Crit Care Med       Date:  2016-03-14       Impact factor: 3.119

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.